Colzyx AB presents Q3 Report – 1 November 2022 – 31 January 2023

“Winter is coming”- well not really here in Lund. As the grey weather persists it is a pleasure to have such an interesting company and product to work with. This was the start I had prepared when writing the report in February. Now it is almost April – so let’s hope for spring and a warm Easter holiday. The WOUNDCOM project has had a busy time with process validation, production for the clinical investigation and establishing shelf life covering the clinical investigation (and more). A discussion with the EIC Fund regarding conversion of the convertible loan and with the European Innovation Council (EIC) regarding prolongation of the project is well on its way.

Are you a shareholder in CBC Derma Technologies AB, CBC Derma Technologies II AB or CBC Derma Technologies III AB? Then please read the note on page 4.

Financial Report 1 November 2022 – 31 January 2023

Colzyx is an R&D company that has not yet generated any revenue from product sales.

The full report can be found HERE.